Table 4.
Analysis of CD38 expression level and survival outcomes in triple negative breast cancers (TNBC) using data from the European Genome–phenome Archive.
Hazard ratio | 95% confidence interval | pValue | |
---|---|---|---|
Disease-free survival (DFS) | |||
CD38 (every 1 unit) | 0.82 | (0.68, 0.97) | 0.0229* |
Overall survival (OS) | |||
CD38 (every 1 unit) | 0.83 | (0.72, 0.97) | 0.0191* |
*Statistically significant.